Background: Peripheral artery disease (PAD) is a prevalent and debilitating condition characterized by reduced blood flow to the lower limb extremities due to arterial plaque buildup. Traditional exercise/walking therapies have been used to improve vascular function and walking performance but suffer from low adherence rates due to pain and discomfort. Heat therapy has emerged as a promising alternative, showing similar improvements in vascular and cardiovascular function, often with higher adherence rates. Summary: This review explores various forms of heat therapy, including passive and active modalities, and their effects on patients with PAD. Heat therapies have demonstrated similar or even superior outcomes compared to traditional exercise/walking therapies, with higher adherence rates. Key Messages: Despite promising results, further research is needed to standardize heat therapy protocol and understand the underlying mechanisms. Optimizing heat therapy could offer a viable, patient-friendly alternative to improve vascular function, reduce pain, and enhance quality of life in patients with PAD.

Peripheral artery disease (PAD) is an atherosclerotic disease predominantly in the peripheral lower extremities. PAD prevalence has significantly increased worldwide and is projected to become an even greater global burden [1, 2]. PAD is a multifactorial disease that originates from various causes such as hypertension, obesity, and aging which contribute to the development of plaque in the conduit arteries in the lower limbs [3, 4]. The accumulation of plaque buildup in the arteries results in arterial stiffness, restricted blood flow, and impaired oxygen delivery, thereby attenuating skeletal muscle function in the lower limbs [5, 6]. Moreover, severe PAD has commonly shown critical limb ischemia and has the potential to block arteries across the body, leading to stroke and myocardial infarction [7‒9]. Although the specific pathophysiological mechanisms of PAD have not been shown yet, targeting skeletal muscle mitochondrial and microcirculatory dysfunction has been suggested as an effective strategy to treat symptoms of PAD [10‒13]. These were further supported by recent studies which reported that mitochondrial-targeted antioxidant therapy improves mitochondrial function and exercise tolerance in the patients with PAD [14‒17]. In order to improve skeletal muscle mitochondrial function, peripheral vascular function, and walking performance, supervised exercise/walking has been used as the first-line treatment for PAD. In vitro studies suggested that supervised exercise/walking may improve endothelial function [18] and mitochondrial respiratory capacity in patients with PAD [19]. Additionally, supervised exercise/walking training has shown improvement in walking performance and quality of life compared to pharmacological and surgical treatment in patients with Fontaine stage II [20‒22].

Although supervised exercise/walking therapies showed beneficial clinical outcomes, the adherence rate of supervised exercise/walking is relatively low due to the leg pain (claudication), cramps, fatigue, and pain during walking which is the most common symptom of PAD and acts as a major barrier for participating in exercise-based therapies [23, 24]. The intermittent claudication is associated with exercise-induced ischemia and is attributed to inflammation and oxidative stress in the leg muscles [25, 26]. Additionally, weight-bearing during walking in the lower limbs has been considered a potential contributor to exercise-induced skeletal muscle ischemia [27]. As a result, the fear of leg pain discourages participation in exercise therapy, inducing deviation from the treatment and poor quality of life [28]. To address this challenge, alternative therapies have been suggested and, interestingly, heat therapy has shown promising results. Recent studies examined the applicability of heat therapy for PAD and reported clinically meaningful outcomes such as delaying ulcers in early-stage PAD [29]. Interestingly, Akerman and colleagues reported that heat therapy could stimulate not only higher adherence rates but also similar functional and cardiovascular improvements to supervised exercise therapies [30]. Likewise, Park and colleagues’ previous study showed that conducting heated water-based walking exercise in PAD was able to significantly improve the cardiovascular function, physical function, and adherence rates, compared to traditional exercise therapy [31, 32].

Although the effects of heat therapy on vascular function, pain, and physical function seem promising, the mechanisms of heat therapy have not yet been well documented (Fig. 1). Considering that patients with PAD are commonly accompanied by diverse comorbidities [33], it is imperative to conduct mechanistic studies of heat therapies in patients with PAD. Furthermore, current and previous heat therapies have utilized inconsistent forms of experimental protocols such as varied temperatures, durations, and heat application locations. Therefore, it will be imperative to document and optimize a standardized protocol for heat therapy with greater mechanistic knowledge, specifically considering thermal conductivity, safety, obesity, age, and dehydration. Thus, the aim of this review was to identify and compare numerous consequences of interventions for PAD treatment, focusing on heat, to document both experimental and clinical considerations, and also to develop optimal protocols for heat therapies in patients with PAD.

Fig. 1.

Heat therapy-induced potential mechanisms for improving vascular and mitochondrial function and inflammatory balance. ROS, reactive oxygen species; O2, superoxide ion; OH, hydroxyl radical; O22, peroxide ion; HSP, heat shock protein; PGC-1α, peroxisome proliferator-activated receptor gamma coactivator 1-alpha; eNOS, endothelial nitric oxide synthase; TNF-α, tumor necrosis factor-alpha; IL-6, interleukin-6; NF-κB, nuclear factor kappa B; NOx, nitrogen oxides; ET-1, endothelin-1.

Fig. 1.

Heat therapy-induced potential mechanisms for improving vascular and mitochondrial function and inflammatory balance. ROS, reactive oxygen species; O2, superoxide ion; OH, hydroxyl radical; O22, peroxide ion; HSP, heat shock protein; PGC-1α, peroxisome proliferator-activated receptor gamma coactivator 1-alpha; eNOS, endothelial nitric oxide synthase; TNF-α, tumor necrosis factor-alpha; IL-6, interleukin-6; NF-κB, nuclear factor kappa B; NOx, nitrogen oxides; ET-1, endothelin-1.

Close modal

This mini review was conducted to summarize the effects of heat therapy in patients with PAD. Studies included in this review were identified through comprehensive searches in PubMed, Scopus, and Web of Science databases. The search strategy included keywords such as “heat therapy,” “peripheral artery disease,” “vascular function,” and “exercise therapy.” We included studies that (1) evaluated passive or active heat therapy as an intervention for PAD, (2) included outcome measures related to vascular function, pain relief, or walking performance, and (3) were published in peer-reviewed journals. Studies specifically targeting patients with intermittent claudication, primarily classified as Fontaine stage II or III, were included. No restrictions were placed on the type, application method, frequency, or duration of heat therapy. Although this is not a systemic review, effort was made to incorporate the most relevant on this topic.

Heat Therapy

Recently, heat therapy has emerged as a potential therapeutic intervention for PAD symptoms, particularly in patients who struggle with the physical demands and pain associated with traditional exercise/walking therapies (Table 1). Interestingly, most research using heat therapy on patients with PAD has shown improved symptoms including walking capacity and vascular health. Passive heat therapy, only heat application, has been reported to provide similar enhancements in vascular function and health outcomes compared to traditional exercise/walking therapies [30]. Active heat therapy, heat with walking exercise, has revealed even greater improvements in walking capacity and cardiovascular health than traditional exercise/walking therapy [32]. Both passive and active heat therapies have demonstrated higher adherence rates than traditional exercise/walking therapy, showing promise to address the limitation of traditional therapies [30, 32]. Although recently the heat therapy as a therapeutic strategy for PAD has been noticeably studied, there are still numerous components such as forms, a wide range of applied temperatures, and multiple combinations should be studied to provide a general guideline. This lack of standardization makes it challenging to comprehensively interpret the benefits of heat therapy. Therefore, it is important to explore and consider specific factors that influence the effectiveness and safety of these interventions.

Table 1.

Summary effects of heat therapy on patients with peripheral artery disease

StudySubjectProtocolMain findingsAdherence rates
Tei et al. [34] (2007) 20 patients with intermittent claudication-to-ulcer Far-infrared dry sauna (15 min in a 60°C + additional 30 min outside with blanket, 5 days/week, for 10 weeks) Pain score ↓ N/A 
Walking distance ↑ 
ABI ↑ 
Blood flow ↑ 
Healed ulcer ↑ 
Shinsato et al. [35] (2010) 21 patients with intermittent claudication divided into far-infrared therapy (n = 11) and con (n = 10) Far-infrared dry sauna (15 min in a 60°C + additional 30 min outside with blanket, 5 days/week, for 6 weeks) Pain score (≈65.4% ↓) All patients (100%) enrolled in the trial completed intervention without any side effects 
ABI (≈9.1% ↑) 
Walking distance (≈54.4% ↑) 
Circulating CD34+ progenitor cells in the periphery (≈95% ↑) 
Serum NOx (≈21.6% ↑) 
↔ VEGF 
Perlow [36] (1933) 20 patients with arterial disease and 8 normal humans Diathermy (2 days/week with current from 750 to 1,000 milliamperes, for 2 months) Pulsation (≈45% ↑) N/A 
Peripheral circulation (≈65% ↑) 
Relieving vasospasm (≈58% ↑) 
Guirro et al. [37] (2015) 15 diabetic women with PAD Short-wave diathermy (a single session for 20 min with moderate heat) ↔ lower limb circulation A single session 
Landry et al. [38] (2021) 10 patients with intermittent claudication Ultrasound therapy (30 min/day at 250 kHz, 3 days/week, for 6 weeks) Walking distance (≈5.68% ↑) N/A 
WIQ (≈31.5% ↑) 
↔ ABI 
Neff et al. [39] (2016) 16 patients with intermittent claudication Thermal garment (a single session for 90 min with 48°C circulating water) Systolic and diastolic BP (≈8% ↓) A single session 
Serum ET-1 (≈60% ↓) 
PA blood flow (≈102% ↑) 
Monroe et al. [40] (2020) 32 patients with symptomatic PAD divided into leg heat therapy (n = 16) and control (n = 16) Thermal garment (90 min/day with 48°C circulating water, 3 days/week, for 6 weeks) Serum ET-1 (≈13% ↓) 15 of 16 (93.7%) completed 98.7% of treatment session 
Perceived physical function (≈6.8 points ↑) 
↔ walking distance 
↔ hemodynamic response 
↔ ABI 
↔ serum NOx 
Monroe et al. [41] (2021) 16 patients with symptomatic PAD Thermal garment (a single session for 90 min with 43°C circulating water) Resting and exercise SBP (∼4 mm Hg <Sham) A single session 
Plasma ET-1 (≈13% ↓) 
↔ cardiopulmonary function 
↔ plasma IL-6 and TNF-α 
↔ onset time of claudication 
↔ muscle oxygenation 
Monroe et al. [42] (2022) 34 patients with symptomatic PAD divided into leg heat therapy (n = 18) and control (n = 16) Thermal garment (90 min/day with 43°C circulating water, 7 days/week, for 8 weeks) Walking distance (≈5.8% ↑) 15 of 18 (83%) completed more than 6 days/week for 8 weeks 
↔ cardiopulmonary function 
↔ hemodynamic response 
Ro et al. [43] (2025) 6 patients with PAD Thermal garment (90 min/day with 41°C circulating water, 7 days/week, for 12 weeks) ↔ BP All patients (100%) enrolled in the trial completed intervention without any side effects 
↔ time for the sit-to-stand test 
↔ walking distance 
↔ strength 
Thomas et al. [44] (2017) PAD (n = 11), control (n = 10) Water immersion (a single session of 30 min waist-level water immersion about 42°C) PA shear rate (≈43% ↑) A single session 
Lower limb blood flow (≈71% ↑) 
BP (≈19.6% ↓) 
Pellinger et al. [45] (2019) 6 patients with PAD Water immersion (a single session of 45 min in 40 cm depth water at 42°C) PA blood flow (≈238.2% ↑) A single session 
Walking distance (≈11.6% ↑) 
Savin et al. [46] (1995) 10 patients with stage II PAD CO2 bath (a single session of 20 min in bath at 35–36°C, followed by enclosed in plastic bag) Femoral blood flow (≈23.1% ↑) A single session 
Tibial pressure (≈7.3% ↑) 
Foot tcPO2 (≈12.3% ↑) 
↔ hemodynamic response 
Hartmann et al. [47] (1997) 18 patients with PAD CO2 bath (a single session of 20 min in 35 cm depth bath at 34°C) PO2 (≈10% ↑) A single session 
Vasomotion amplitude (≈300% ↑) 
Makita et al. [48] (2006) 16 patients with Fontaine grade II PAD divided into CO2 bath (n = 8) and control (n = 8) CO2 bath (10 min/day in bath at 35°C, 7 days/week, for 3 weeks) Skin blood flow (≈426% ↑) N/A 
Pain at rest (≈75% ↓) 
Dogliotti et al. [49] (2011) Fontaine stage II PAD (n = 25) control (n = 15) CO2 bath (20 min/day in 35 cm depth bath at 34°C, 5 days/week, for 2 weeks) ↑ serum TAS N/A 
↓ plasma ROMs 
Toriyama et al. [50] (2002) 83 patients with Fontaine IV PAD CO2 bath (10 min in bath at 37°C, twice daily, for 2 months) Salvage rate (≈68.6% ↑) N/A 
Blood flow (≈3.2% ↑) tcPO2 (≈17.5% ↑) 
LF/HF ratio (≈17.5% ↓) 
Al-Jazzar et al. [51] (2012) 7 patients with PAD Aquatic exercise (50 min/day in waist-to-chest level water at 28–30°C, 3 days/week, for 12 weeks) ABI (≈16.7% ↑) N/A 
Toe pressure (≈18.1% ↑) 
Walking distance (≈134.6% ↑) 
Akerman et al. [30] (2019) 22 patients with PAD divided into HT (n = 11) and SE (n = 11) Water immersion followed by exercise (30 min/day shoulder-to-xiphoid level water immersion at 39°C followed by 30 min/day calisthenics with warm clothing, 3–5 days/week, for 12 weeks) Walking distance (≈14.7% ↑) 10 of 11 (90.9%) completed HT more than 3 days/week 
Onset time of claudication (≈20.1% ↑) 
BP (SBP: ≈ 4.6% ↓, DBP: ≈ 5.8% ↓, MAP: ≈ 4.6% ↓) 
↔ ABI 
↔ vascular health 
Park et al. [31] (2019) 72 patients with PAD divided into AQ (n = 35) and control (n = 37) Aquatic exercise (60 min/day in waist-to-chest level water at 28–30°C, 4 days/week, for 12 weeks) Leg PWV (≈20.3% ↓) 35 of 42 (83%) completed intervention 
Walking distance (≈12.8% ↑) 
Cardiorespiratory fitness (≈13.3% ↑) 
Perceived physical function (≈13% ↑) 
Handgrip and leg strength (≈4.5% ↑) 
Park et al. [32] (2020) 63 patients with PAD divided into AQ (n = 32) and SE (n = 31) Aquatic exercise (60 min/day in waist-to-chest level water at 28–30°C, 4 days/week, for 12 weeks) PWV (legPWV: ≈ 1.2 m/s ↓, baPWV: ≈ 0.7 m/s ↓) 28 of 32 (87.5%) completed AQ 
Walking distance (≈60 m ↑) 
Onset time of claudication (≈85 s ↑) 
Resting metabolic rate (≈5.9% ↑) 
Quarto et al. [52] (2017) 98 patients with Fontaine II PAD divided into AQ (n = 47) and SE (n = 45) Aquatic exercise (60 min/day in 50–60 cm water at 28–30°C and 24–26°C, at least 3 days/week, for 12 weeks) Walking distance (≈44.9% ↑) N/A 
Onset time of claudication (≈43.8% ↑) 
FMD (≈34.8% ↑) 
C-HDL (≈5.7% ↑) 
TNF-α (≈50% ↓) and reactive protein C (≈33.3% ↓) 
Lipid level (triglycerides: ≈ 
24.5% ↓, total cholesterol: ≈ 
12.7% ↓, C-LDL: ≈ 11% ↓) 
StudySubjectProtocolMain findingsAdherence rates
Tei et al. [34] (2007) 20 patients with intermittent claudication-to-ulcer Far-infrared dry sauna (15 min in a 60°C + additional 30 min outside with blanket, 5 days/week, for 10 weeks) Pain score ↓ N/A 
Walking distance ↑ 
ABI ↑ 
Blood flow ↑ 
Healed ulcer ↑ 
Shinsato et al. [35] (2010) 21 patients with intermittent claudication divided into far-infrared therapy (n = 11) and con (n = 10) Far-infrared dry sauna (15 min in a 60°C + additional 30 min outside with blanket, 5 days/week, for 6 weeks) Pain score (≈65.4% ↓) All patients (100%) enrolled in the trial completed intervention without any side effects 
ABI (≈9.1% ↑) 
Walking distance (≈54.4% ↑) 
Circulating CD34+ progenitor cells in the periphery (≈95% ↑) 
Serum NOx (≈21.6% ↑) 
↔ VEGF 
Perlow [36] (1933) 20 patients with arterial disease and 8 normal humans Diathermy (2 days/week with current from 750 to 1,000 milliamperes, for 2 months) Pulsation (≈45% ↑) N/A 
Peripheral circulation (≈65% ↑) 
Relieving vasospasm (≈58% ↑) 
Guirro et al. [37] (2015) 15 diabetic women with PAD Short-wave diathermy (a single session for 20 min with moderate heat) ↔ lower limb circulation A single session 
Landry et al. [38] (2021) 10 patients with intermittent claudication Ultrasound therapy (30 min/day at 250 kHz, 3 days/week, for 6 weeks) Walking distance (≈5.68% ↑) N/A 
WIQ (≈31.5% ↑) 
↔ ABI 
Neff et al. [39] (2016) 16 patients with intermittent claudication Thermal garment (a single session for 90 min with 48°C circulating water) Systolic and diastolic BP (≈8% ↓) A single session 
Serum ET-1 (≈60% ↓) 
PA blood flow (≈102% ↑) 
Monroe et al. [40] (2020) 32 patients with symptomatic PAD divided into leg heat therapy (n = 16) and control (n = 16) Thermal garment (90 min/day with 48°C circulating water, 3 days/week, for 6 weeks) Serum ET-1 (≈13% ↓) 15 of 16 (93.7%) completed 98.7% of treatment session 
Perceived physical function (≈6.8 points ↑) 
↔ walking distance 
↔ hemodynamic response 
↔ ABI 
↔ serum NOx 
Monroe et al. [41] (2021) 16 patients with symptomatic PAD Thermal garment (a single session for 90 min with 43°C circulating water) Resting and exercise SBP (∼4 mm Hg <Sham) A single session 
Plasma ET-1 (≈13% ↓) 
↔ cardiopulmonary function 
↔ plasma IL-6 and TNF-α 
↔ onset time of claudication 
↔ muscle oxygenation 
Monroe et al. [42] (2022) 34 patients with symptomatic PAD divided into leg heat therapy (n = 18) and control (n = 16) Thermal garment (90 min/day with 43°C circulating water, 7 days/week, for 8 weeks) Walking distance (≈5.8% ↑) 15 of 18 (83%) completed more than 6 days/week for 8 weeks 
↔ cardiopulmonary function 
↔ hemodynamic response 
Ro et al. [43] (2025) 6 patients with PAD Thermal garment (90 min/day with 41°C circulating water, 7 days/week, for 12 weeks) ↔ BP All patients (100%) enrolled in the trial completed intervention without any side effects 
↔ time for the sit-to-stand test 
↔ walking distance 
↔ strength 
Thomas et al. [44] (2017) PAD (n = 11), control (n = 10) Water immersion (a single session of 30 min waist-level water immersion about 42°C) PA shear rate (≈43% ↑) A single session 
Lower limb blood flow (≈71% ↑) 
BP (≈19.6% ↓) 
Pellinger et al. [45] (2019) 6 patients with PAD Water immersion (a single session of 45 min in 40 cm depth water at 42°C) PA blood flow (≈238.2% ↑) A single session 
Walking distance (≈11.6% ↑) 
Savin et al. [46] (1995) 10 patients with stage II PAD CO2 bath (a single session of 20 min in bath at 35–36°C, followed by enclosed in plastic bag) Femoral blood flow (≈23.1% ↑) A single session 
Tibial pressure (≈7.3% ↑) 
Foot tcPO2 (≈12.3% ↑) 
↔ hemodynamic response 
Hartmann et al. [47] (1997) 18 patients with PAD CO2 bath (a single session of 20 min in 35 cm depth bath at 34°C) PO2 (≈10% ↑) A single session 
Vasomotion amplitude (≈300% ↑) 
Makita et al. [48] (2006) 16 patients with Fontaine grade II PAD divided into CO2 bath (n = 8) and control (n = 8) CO2 bath (10 min/day in bath at 35°C, 7 days/week, for 3 weeks) Skin blood flow (≈426% ↑) N/A 
Pain at rest (≈75% ↓) 
Dogliotti et al. [49] (2011) Fontaine stage II PAD (n = 25) control (n = 15) CO2 bath (20 min/day in 35 cm depth bath at 34°C, 5 days/week, for 2 weeks) ↑ serum TAS N/A 
↓ plasma ROMs 
Toriyama et al. [50] (2002) 83 patients with Fontaine IV PAD CO2 bath (10 min in bath at 37°C, twice daily, for 2 months) Salvage rate (≈68.6% ↑) N/A 
Blood flow (≈3.2% ↑) tcPO2 (≈17.5% ↑) 
LF/HF ratio (≈17.5% ↓) 
Al-Jazzar et al. [51] (2012) 7 patients with PAD Aquatic exercise (50 min/day in waist-to-chest level water at 28–30°C, 3 days/week, for 12 weeks) ABI (≈16.7% ↑) N/A 
Toe pressure (≈18.1% ↑) 
Walking distance (≈134.6% ↑) 
Akerman et al. [30] (2019) 22 patients with PAD divided into HT (n = 11) and SE (n = 11) Water immersion followed by exercise (30 min/day shoulder-to-xiphoid level water immersion at 39°C followed by 30 min/day calisthenics with warm clothing, 3–5 days/week, for 12 weeks) Walking distance (≈14.7% ↑) 10 of 11 (90.9%) completed HT more than 3 days/week 
Onset time of claudication (≈20.1% ↑) 
BP (SBP: ≈ 4.6% ↓, DBP: ≈ 5.8% ↓, MAP: ≈ 4.6% ↓) 
↔ ABI 
↔ vascular health 
Park et al. [31] (2019) 72 patients with PAD divided into AQ (n = 35) and control (n = 37) Aquatic exercise (60 min/day in waist-to-chest level water at 28–30°C, 4 days/week, for 12 weeks) Leg PWV (≈20.3% ↓) 35 of 42 (83%) completed intervention 
Walking distance (≈12.8% ↑) 
Cardiorespiratory fitness (≈13.3% ↑) 
Perceived physical function (≈13% ↑) 
Handgrip and leg strength (≈4.5% ↑) 
Park et al. [32] (2020) 63 patients with PAD divided into AQ (n = 32) and SE (n = 31) Aquatic exercise (60 min/day in waist-to-chest level water at 28–30°C, 4 days/week, for 12 weeks) PWV (legPWV: ≈ 1.2 m/s ↓, baPWV: ≈ 0.7 m/s ↓) 28 of 32 (87.5%) completed AQ 
Walking distance (≈60 m ↑) 
Onset time of claudication (≈85 s ↑) 
Resting metabolic rate (≈5.9% ↑) 
Quarto et al. [52] (2017) 98 patients with Fontaine II PAD divided into AQ (n = 47) and SE (n = 45) Aquatic exercise (60 min/day in 50–60 cm water at 28–30°C and 24–26°C, at least 3 days/week, for 12 weeks) Walking distance (≈44.9% ↑) N/A 
Onset time of claudication (≈43.8% ↑) 
FMD (≈34.8% ↑) 
C-HDL (≈5.7% ↑) 
TNF-α (≈50% ↓) and reactive protein C (≈33.3% ↓) 
Lipid level (triglycerides: ≈ 
24.5% ↓, total cholesterol: ≈ 
12.7% ↓, C-LDL: ≈ 11% ↓) 

Percentages were directly calculated based on reported values in the original studies.

PAD, peripheral artery disease; SE, supervised exercise; HE, home-based exercise; AQ, aquatic exercise; HT, heat therapy; ABI, ankle-brachial index; CD34, cluster of differentiation 34; NOx, nitrogen oxides; VEGF, vascular endothelial growth factor; WIQ, walking impairment questionnaire; ET-1, endothelin-1; PA, popliteal artery; IL-6, interleukin-6; TNF-α, tumor necrosis factor-alpha; TAS, total antioxidant status; ROMs, reactive oxygen metabolites; LF/HF ratio, low frequency to high frequency ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; PO2, partial pressure of oxygen; PWV, pulse wave velocity; baPWV, brachial artery pulse wave velocity; FMD, flow-mediated dilation; C-HDL, high-density lipoprotein cholesterol; C-LDL, low-density lipoprotein cholesterol; ↑, increase; ↓, decrease; ↔, no change.

Passive Heat Therapy

Wave Frequency

Common passive heat therapy such as far-infrared-ray sauna therapy, known as Waon therapy, utilized a wide wave spectrum of electromagnetic frequencies (3–25 μm) for PAD treatment [34]. This spectrum allows for deeper tissue penetration, reaching muscles and even the blood vessels in the deeper layers, making it suitable for treating PAD symptoms. These passive heat therapies utilizing a wide wave consists of dry sauna for 15 min at 45–60°C without hydration pressure, followed by supine rest with blankets for an additional 30 min. These therapies recommended to undergo 5 days per week for 10 weeks. Waon therapy has shown favorable effects across various PAD classifications (from Fontaine II to Fontaine IV). Treatment at 60°C significantly improved pain score, walking distance, ankle-brachial index, blood flow in patients with intermittent claudication and pain at rest, and even facilitated the healing of toe ulcers [34]. Treatment at 45°C also was effective in healing digital ulcer [53]. However, the heat therapies using a wide wave reported some mild adverse effects, such as leg pain during sauna sessions [35], along with mild claustrophobia and bronchitis, which led to dropouts in some cases [54]. Another passive heat therapy option is short-wave or microwave diathermy, which penetrates deep tissues. This therapy produces heat and is primarily used for topical application. The therapy typically requires 2 to 3 times per week at 37–43°C. The effectiveness of diathermy remains debated. Some studies indicated that it can immediately and chronically improve pulsation in patients with arterial disturbances in the lower extremities [36], while others suggested that it does not reduce blood flow velocity in patients with PAD compared to active exercise or shock wave therapy, which stimulates blood flow supply by causing a small amount of inflammation rather than generating heat [37]. Additionally, diathermy carries a higher risk of burn injuries due to direct heating of deep tissue [55], and precautions should be taken to remove any metallic materials near the treatment area [56]. Finally, therapeutic ultrasound, which uses acoustic waves, has promoted angiogenesis in clinically relevant animal models, including type 2 diabetic mice, hypertensive rats with PAD, and rats with hindlimb ischemia [57‒59]. A clinical study involving 30-min sessions, 3 days per week for 6 weeks at 250 kHz, showed increased walking performance in patients with PAD, but ankle-brachial index did not significantly increase [38].

Passive Heat Therapy with Thermal Garment

Passive heat therapy using thermal garments (90 min per session, more than 3 times per week for at least 6 weeks at 41–48°C) reported a significant improvement in vascular function in patients with PAD. Neff and colleagues found that a single bout of passive heat therapy with thermal garment could lower serum endothelin-1 concentration and blood pressure while increasing blood flow in patients with PAD [39]. Similarly, Monroe and colleagues, using the same protocol, found improvements in endothelin-1 and blood pressure, along with extended peak walking tolerance, but muscle oxygenation and onset time of claudication showed no improvement compared to the sham treatment group [41]. These findings are consistent with their other studies which induced chronic heat application with thermal garment for 6 weeks, and they found a decrease in endothelin-1 and improved perceived physical function without improvement in walking performance [40]. Although the practicality of thermal garments have been demonstrated by showing higher adherence rates [40, 42, 43], the inconsistent findings regarding its effects on walking capacity and hemodynamic responses [39‒43] warrant further investigation.

Passive Heat Therapy with Warm/Hot Immersion

Passive heat therapy with water immersion involving sessions at the water temperature of 39–42°C for 30–45 min, and the therapy has shown both acute and chronic benefits for patients with PAD. Thomas and colleagues reported that waist-level water immersion at 42°C for 30 min significantly improved blood flow in the lower limbs [44]. Similarly, Pellinger and colleagues observed increases blood flow in the lower limbs and walking distance with shallow water immersions (40 cm depth) for a shorter duration of 15 min at 42°C as well as for 45 min duration [45]. Furthermore, applying waist-level water immersion at 40.5°C for 60 min over 36 sessions across 8 weeks to sedentary individuals who are at potential risk for PAD [60] showed an enhanced nitric oxide dependent vasodilatory function in forearm and arterial compliance in lower limbs, and reduced pulse wave velocity [61, 62]. In addition, passive heat therapy with warm/hot water immersion showed better thermal comfort compared to heated air-based therapy. For example, heated air-based therapy, such as the Finnish sauna [63], has been conducted in patients with other cardiovascular diseases like hypertension and heart failure and healthy individuals, but not yet in patients with PAD. Despite similar increases in plasma anti-inflammatory cytokine levels at matched core temperatures, forced air heating caused higher thermal discomfort than warm/hot water immersion [64]. Despite greater than 90% of adherence, completion and positive consequences associated with passive heat therapy with water immersion [44], multiple variation in protocols, and the limited number of studies makes it challenging to comprehensively interpret the results.

Passive Heat Therapy with Carbon Dioxide Bath

The Bohr effect is a phenomenon that describes how hemoglobin’s affinity for oxygen is reduced in the presence of increased carbon dioxide, CO2, facilitating the release of oxygen (O2) to tissues and increase O2 perfusion and tissue oxygenation. In CO2 bathing, this effect is induced artificially, with optimal bath conditions maintained at an approximately 1,000 ppm CO2 concentration and temperatures of 34–41°C for 10–20 min per session. These baths are usually administered more than 5 times a week for at least 4 weeks. At higher temperatures, the binding affinity of oxygen to hemoglobin further decreases, shifting the oxygen dissociation curve to the right. Given these characteristics, CO2 baths are often combined with thermal gas or water therapy to enhance therapeutic effects. Like other heat therapies, both acute and chronic improvement in pain relief and vascular function were induced by CO2 bath. Acute CO2 bath with thermal gas and water were effective in local vasomotor function and oxygen availability in the muscle tissues in patients with Fontaine stage II PAD [46, 47], repeated CO2 baths alleviated pain and plasma free radical, and elevated blood flow and antioxidant levels by increased oxygenation in patients with stage II of PAD [48, 49]. Increased frequency, duration, and temperature of CO2 baths even protected ulcer or gangrene limbs from amputation in patients with stage IV of PAD via raise of blood flow in the peripheral tissues in the limbs [50]. Interestingly, an animal study suggested that there is a CO2 bath temperature dependent positive effects appeared in the rats with hindlimb ischemia [65]. For example, CO2 baths with 34°C caused higher blood flow in ischemic limbs compared to 41°C, but CO2 bath with 41°C resulted in higher vascular density compared to 34°C. Despite the promising results, there was no available report/data on adherence rates in patients with PAD, making it unclear whether it has the potential to overcome the limitation of traditional exercise/walking therapies.

Active Heat Therapy

Active Heat Therapy with Aquatic Exercise

Aquatic exercise in the heated water, allows patients with PAD to benefit from both the effects of heat therapy and exercise. The buoyancy provided by water reduces weight-bearing stress, enabling patients with PAD to participate without the fear or burden of pain. At the same time, the water-induced drag imposes the intensity of movement. The combination of internal heat generated by exercise and external heat from the heated water may induce potential synergistic effects in mitigating PAD symptoms. Indeed, previous studies investigated aquatic exercise in patients with PAD and have reported positive health outcomes. Aquatic exercise in the heated water typically involves waist-to-chest depth immersion at 28–39°C for 30 min, 3 times per week for 12 weeks [31, 32, 51]. These active therapies have been shown to lower arterial stiffness and ameliorate cardiorespiratory fitness, exercise tolerance, and physical function [32, 51]. Aquatic exercise has also demonstrated a greater efficacy in improving cardiovascular and physical functions compared to supervised exercise/walking therapies [32]. Even when conducted in shallower water (50–60 cm depth), aquatic exercise resulted in better walking capability and vascular reactivity compared to supervised exercise/walking therapies [52]. Additionally, studies have generally reported positive adherence rates except for one study. Al-Jazzar and colleagues observed low adherence to aquatic exercise, with only 7 out of 20 patients completing the entire program. They speculated that it might be due to inconveniences such as the need to change into specialized equipment and the distance of the facility [51]. Their protocol included supplemental devices like hydro-tone boots and water cycling, which may have contributed to the discomfort. In contrast, Quarto and colleagues reported that aquatic exercise in the heated water was safe and well tolerated by patients with PAD, though they did not provide specific adherence data [52]. Additionally, Park and colleagues’ previous studies identified high adherence to aquatic exercise in the heated water, which were higher than those of supervised exercise/walking therapies [31, 32]. These studies suggest that heat therapy with aquatic exercise can overperform traditional exercise/walking therapy in terms of effectiveness and adherence, along with the relatively identical protocol. However, further research is needed due to the limited number of accessible studies.

Other Active Heat Therapy

Several active heat therapies have recently been explored for cardiovascular benefits, though not specifically targeted toward patients with PAD. These therapies were often integrated with pre-, during-, and post-exercise interventions. For instance, Akerman and colleagues used 30-min sessions with immersion up to the xiphoid process and shoulders in 39°C water, followed by 15–30 min of warm clothing and calisthenic exercises. The results showed significant improvements in cardiovascular health and walking distance after 12 weeks of heated water therapy in patients with PAD. Additionally, this study reported that the heated water therapy showed relatively higher adherence rates compared to other types of heat therapies [30].

Yoga with heat application, commonly known as hot yoga, has been shown to improve endothelial function, arterial stiffness, cholesterol levels, blood pressure, and overall physical functional capacity in healthy adults across various age groups [66, 67]. Hot yoga in healthy young adults induced cellular and neural adaptations, such as increased expression of heat shock protein 70 in peripheral blood mononuclear cells and serum brain-derived neurotrophic factor [68]. It has also demonstrated beneficial effects in overweight and obese individuals. For instance, Guo and colleagues reported improvements in lipid profiles, body fat percentage, and blood pressure among overweight women [69]. Additionally, insulin resistance and arterial stiffness improvements were observed in older obese adults and young overweight adults, respectively [70]. Similarly, aerobic exercise with sauna suit has showed improvement in cardiorespiratory fitness and cardiometabolic risk factors in physically active young to middle-aged adults [71]. Endurance exercise with sauna bathing showed significant improvement in blood pressure compared to an acute strength exercise with sauna bathing and sauna alone in healthy and prehypertensive men [72]. Moreover, 8 weeks of cycling exercise with sauna bathing provided supplemental benefits for cardiorespiratory fitness, systolic blood pressure, and total cholesterol levels compared to cycling exercise alone in middle-aged adults with sedentary lifestyles [73].

Passive heat therapy with thermal garments has been shown to effectively reduce arterial stiffness; however, aerobic exercise performed in a hot environment has been found to increase arterial stiffness in middle-aged adults [74]. Furthermore, even short-term exercise in hot environments significantly increased heat loss capacity and produced heat stress [75, 76]. Therefore, the application of the heat therapy should take into account environmental factors such as humidity and temperature.

Adherence Rates

No matter how effective therapies are, participation is the most critical in determining the degree of effects. Adherence rates depend on various factors such as the appeal and accessibility of the protocols. Passive heat therapies generally have higher adherence rates (Table 1) and might be due to their less physically demanding nature. For instance, wave frequency, thermal garments, and water immersion therapy have shown adherence rates above 90%. In contrast, active therapies, such as aquatic exercise, may have lower adherence due to the effort required. However, adherence rates were available in only few studies of heat therapy. In order to conclude whether heat therapy is optimal therapy to overcome the limitation of traditional therapies, further investigation is needed on adherence rates.

Potential Mechanisms

In other disease conditions, heat therapy exerts its therapeutic effects through multiple physiological mechanisms. First, it enhances endothelial function by increasing nitric oxide bioavailability, leading to improved vasodilation and perfusion in ischemic tissues [61, 77, 78]. Second, heat exposure upregulates heat shock protein and heat shock factor 1, which protect against oxidative stress [79, 80] and inflammation-induced endothelial dysfunction [81]. Additionally, repeated heat exposure has been shown to modulate pro-inflammatory cytokines such as tumor necrosis factor-a while increasing anti-inflammatory mediators [82, 83], thereby modulating the chronic inflammatory state observed in patients with PAD. Furthermore, heat therapy can enhance mitochondrial biogenesis [84] and oxidative capacity in skeletal muscle [85, 86], which may contribute to improved walking endurance and physical function in patients with PAD. These mechanisms collectively support the potential of heat therapy as an alternative or complementary treatment for PAD (Fig. 1).

Considerations for Heat Therapies

In order to overcome the limitations of traditional walking therapies, various alternative trials have been examined to increase exercise compliance. Although both passive and active heat therapies reported significant health benefits to patients with PAD, there are a number of factors to consider for the heat applications. First, aging is positively correlated with the prevalence of PAD [87]. Aging can cause abnormal thermal sensitivity [88], which may suppress the effects of heat therapy in patients with PAD. During local heating, endothelial nitric oxide synthase (eNOS) was blunted in middle-aged and elderly individuals [89, 90]. Second, obesity has known to be associated with a higher prevalence of PAD [1]. Likewise, obesity can induce an abnormal thermal threshold [91], and Stephens and colleagues previously demonstrated that thermal responses to hot water immersion varied and dependent upon body composition such as body fat mass and fat percentage [92]. Consequently, aging and obesity-induced dysfunction of thermal sensitivity may require higher and longer heat application to achieve beneficial effects in patients with PAD [93, 94]. However, patients with PAD are more susceptible to burns or other skin problems, due to age-mediated hair loss and skin atrophy [95]. Indeed, some studies reported non-perceived skin or tissue injury can occur and the skin irritation/injury can be a cause of dropout during heat therapy [40, 42]. Therefore, it is imperative to find a proper heat temperature ranges to maximize the health benefits in patients with PAD.

Additionally, perspiration is also a crucial consideration when applying heat therapy to patients with PAD. Heat exposure naturally increases sweat production as the body attempts to regulate its temperature, and even local heat application can increase skin temperature and accentuate sweating [96]. Likewise, patients with PAD may have attenuated function of perspiration due to the attenuated blood flow to the peripheral extremities which impairs normal sweating and further increasing the risk of overheating with significant fluid loss, resulting in dehydration in patients with PAD. Lowe and colleagues suggested that dehydration can increase blood viscosity, thereby placing additional stress on the cardiovascular system and exacerbating PAD symptoms such as pain and cramping [97]. Moreover, the rise in blood viscosity heightens the risk of coagulation, particularly in patients with PAD who are already susceptible to blood clot formation due to impaired circulation [97]. This combination of dehydration and increased coagulation risks require careful monitoring and management during heat therapy to avoid potential complications. Therefore, proper hydration and careful adjustment of heat therapy protocols are essential to manage these risks effectively.

Heat therapy presents a compelling alternative to traditional exercise/walking therapies for the treatment of PAD. The higher adherence rates and promising clinical outcomes make it an attractive option, particularly for patients who struggle with the physical demands of exercise due to pain or other limitations. However, the lack of standardized protocols and mechanistic understanding of its benefits highlight the need for further research. Studies should focus on optimizing heat therapy protocols, considering variables such as temperature, duration, and patient characteristics like age and obesity. By addressing these gaps, heat therapy could become a key treatment strategy in improving vascular function, reducing pain, and enhancing overall quality of life for patient with PAD.

No conflicts of interest, financial or otherwise, are declared by the authors.

This article was supported by the Dong-A University research fund, and University of Nebraska at Omaha.

M.-H.J.: writing – review and editing, writing – original draft, visualization, methodology, and conceptualization. S.-Y.P.: writing – review and editing, writing – original draft, supervision, project administration, and conceptualization. S.D.K.: writing – review and editing and visualization. S.H.L.: writing – review and editing, supervision, project administration, and conceptualization.

Additional Information

Min-Hyeok Jang and Song-Young Park contributed equally to this work.

1.
Fowkes
FGR
,
Aboyans
V
,
Fowkes
FJI
,
McDermott
MM
,
Sampson
UKA
,
Criqui
MH
.
Peripheral artery disease: epidemiology and global perspectives
.
Nat Rev Cardiol
.
2017
;
14
(
3
):
156
70
.
2.
Song
P
,
Rudan
D
,
Zhu
Y
,
Fowkes
FJI
,
Rahimi
K
,
Fowkes
FGR
, et al
.
Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis
.
Lancet Glob Health
.
2019
;
7
(
8
):
e1020
30
.
3.
Ouriel
K
.
Peripheral arterial disease
.
Lancet
.
2001
;
358
(
9289
):
1257
64
.
4.
Rocha-Singh
KJ
,
Zeller
T
,
Jaff
MR
.
Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications
.
Catheter Cardiovasc Interv
.
2014
;
83
(
6
):
212
20
.
5.
Zieman
SJ
,
Melenovsky
V
,
Kass
DA
.
Mechanisms, pathophysiology, and therapy of arterial stiffness
.
Arterioscler Thromb Vasc Biol
.
2005
;
25
(
5
):
932
43
.
6.
Palombo
C
,
Kozakova
M
.
Arterial stiffness, atherosclerosis and cardiovascular risk: pathophysiologic mechanisms and emerging clinical indications
.
Vascul Pharmacol
.
2016
;
77
:
1
7
.
7.
Norgren
L
,
Hiatt
WR
,
Dormandy
JA
,
Nehler
MR
,
Harris
KA
,
Fowkes
FGR
, et al
.
Inter-society consensus for the management of peripheral arterial disease (TASC II)
.
J Vasc Surg
.
2007
;
45
(
Suppl S
):
S5
67
.
8.
Rooke
TW
,
Hirsch
AT
,
Misra
S
,
Sidawy
AN
,
Beckman
JA
,
Findeiss
LK
, et al
.
ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the american college of cardiology foundation/American Heart Association task force on practice guidelin
.
Circulation
.
2011
;
124
(
18
):
2020
45
.
9.
European Stroke Organisation
,
Tendera
M
,
Aboyans
V
,
Bartelink
ML
,
Baumgartner
I
,
Clément
D
,
Collet
JP
, et al
.
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)
.
Eur Heart J
.
2011
;
32
(
22
):
2851
906
.
10.
Rontoyanni
VG
,
Nunez Lopez
O
,
Fankhauser
GT
,
Cheema
ZF
,
Rasmussen
BB
,
Porter
C
.
Mitochondrial bioenergetics in the metabolic myopathy accompanying peripheral artery disease
.
Front Physiol
.
2017
;
8
:
141
.
11.
Hart
CR
,
Layec
G
,
Trinity
JD
,
Kwon
OS
,
Zhao
J
,
Reese
VR
, et al
.
Increased skeletal muscle mitochondrial free radical production in peripheral arterial disease despite preserved mitochondrial respiratory capacity
.
Exp Physiol
.
2018
;
103
(
6
):
838
50
.
12.
Kim
K
,
Anderson
EM
,
Scali
ST
,
Ryan
TE
.
Skeletal muscle mitochondrial dysfunction and oxidative stress in peripheral arterial disease: a unifying mechanism and therapeutic target
.
Antioxidants
.
2020
;
9
(
12
):
1304
23
.
13.
Park
SY
,
Pekas
EJ
,
Anderson
CP
,
Kambis
TN
,
Mishra
PK
,
Schieber
MN
, et al
.
Impaired microcirculatory function, mitochondrial respiration, and oxygen utilization in skeletal muscle of claudicating patients with peripheral artery disease
.
Am J Physiol Heart Circ Physiol
.
2022
;
322
(
5
):
H867
79
.
14.
Ismaeel
A
,
McDermott
MM
,
Joshi
JK
,
Sturgis
JC
,
Zhang
D
,
Ho
KJ
, et al
.
Cocoa flavanols, Nrf2 activation, and oxidative stress in peripheral artery disease: mechanistic findings in muscle based on outcomes from a randomized trial
.
Am J Physiol Cell Physiol
.
2024
;
326
(
2
):
C589
605
.
15.
Brevetti
G
,
Chiariello
M
,
Ferulano
G
,
Policicchio
A
,
Nevola
E
,
Rossini
A
, et al
.
Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study
.
Circulation
.
1988
;
77
(
4
):
767
73
.
16.
Hiatt
WR
,
Regensteiner
JG
,
Creager
MA
,
Hirsch
AT
,
Cooke
JP
,
Olin
JW
, et al
.
Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication
.
Am J Med
.
2001
;
110
(
8
):
616
22
.
17.
Park
SY
,
Pekas
EJ
,
Headid
RJ
3rd
,
Son
WM
,
Wooden
TK
,
Song
J
, et al
.
Acute mitochondrial antioxidant intake improves endothelial function, antioxidant enzyme activity, and exercise tolerance in patients with peripheral artery disease
.
Am J Physiol Heart Circ Physiol
.
2020
;
319
(
2
):
H456
67
.
18.
Novakovic
M
,
Jug
B
,
Lenasi
H
.
Clinical impact of exercise in patients with peripheral arterial disease
.
Vascular
.
2017
;
25
(
4
):
412
22
.
19.
van Schaardenburgh
M
,
Wohlwend
M
,
Rognmo
Ø
,
Mattsson
EJR
.
Exercise in claudicants increase or decrease walking ability and the response relates to mitochondrial function
.
J Transl Med
.
2017
;
15
(
1
):
130
.
20.
Girolami
B
,
Bernardi
E
,
Prins
MH
,
Ten Cate
JW
,
Hettiarachchi
R
,
Prandoni
P
, et al
.
Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl A meta-analysis
.
Arch Intern Med
.
1999
;
159
(
4
):
337
45
.
21.
Spronk
S
,
Bosch
JL
,
Den Hoed
PT
,
Veen
HF
,
Pattynama
PMT
,
Hunink
MGM
.
Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training-randomized controlled trial
.
Radiology
.
2009
;
250
(
2
):
586
95
.
22.
Murphy
TP
,
Cutlip
DE
,
Regensteiner
JG
,
Mohler
ER
3rd
,
Cohen
DJ
,
Reynolds
MR
, et al
.
Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study
.
J Am Coll Cardiol
.
2015
;
65
(
10
):
999
1009
.
23.
Galea
MN
,
Bray
SR
,
Ginis
KAM
.
Barriers and facilitators for walking in individuals with intermittent claudication
.
J Aging Phys Act
.
2008
;
16
(
1
):
69
84
.
24.
Barbosa
JP
,
Farah
BQ
,
Chehuen
M
,
Cucato
GG
,
Farias Júnior
JC
,
Wolosker
N
, et al
.
Barriers to physical activity in patients with intermittent claudication
.
Int J Behav Med
.
2015
;
22
(
1
):
70
6
.
25.
Hiatt
WR
,
Armstrong
EJ
,
Larson
CJ
,
Brass
EP
.
Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease
.
Circ Res
.
2015
;
116
(
9
):
1527
39
.
26.
Tisi
PV
,
Shearman
CP
.
The evidence for exercise-induced inflammation in intermittent claudication: should we encourage patients to stop walking
.
Eur J Vasc Endovasc Surg
.
1998
;
15
(
1
):
7
17
.
27.
Nawaz
S
,
Walker
RD
,
Wilkinson
CH
,
Saxton
JM
,
Pockley
AG
,
Wood
RFM
.
The inflammatory response to upper and lower limb exercise and the effects of exercise training in patients with claudication
.
J Vasc Surg
.
2001
;
33
(
2
):
392
9
.
28.
Spronk
S
,
White
JV
,
Bosch
JL
,
Hunink
MGM
.
Impact of claudication and its treatment on quality of life
.
Semin Vasc Surg
.
2007
;
20
(
1
):
3
9
.
29.
Anderson
CP
,
Pekas
EJ
,
Park
SY
.
Microvascular dysfunction in peripheral artery disease: is heat therapy a viable treatment
.
Int J Environ Res Public Health
.
2021
;
18
(
5
):
2384
15
.
30.
Akerman
AP
,
Thomas
KN
,
van Rij
AM
,
Body
ED
,
Alfadhel
M
,
Cotter
JD
.
Heat therapy vs. Supervised exercise therapy for peripheral arterial disease: a 12-wk randomized, controlled trial
.
Am J Physiol Heart Circ Physiol
.
2019
;
316
(
6
):
H1495
506
.
31.
Park
SY
,
Kwak
YS
,
Pekas
EJ
.
Impacts of aquatic walking on arterial stiffness, exercise tolerance, and physical function in patients with peripheral artery disease: a randomized clinical trial
.
J Appl Physiol
.
2019
;
127
(
4
):
940
9
.
32.
Park
SY
,
Wong
A
,
Son
WM
,
Pekas
EJ
.
Effects of heated water-based versus land-based exercise training on vascular function in individuals with peripheral artery disease
.
J Appl Physiol
.
2020
;
128
(
3
):
565
75
.
33.
Diehm
C
,
Schuster
A
,
Allenberg
JR
,
Darius
H
,
Haberl
R
,
Lange
S
, et al
.
High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study
.
Atherosclerosis
.
2004
;
172
(
1
):
95
105
.
34.
Tei
C
,
Shinsato
T
,
Miyata
M
,
Kihara
T
,
Hamasaki
S
.
Waon therapy improves peripheral arterial disease
.
J Am Coll Cardiol
.
2007
;
50
(
22
):
2169
71
.
35.
Shinsato
T
,
Miyata
M
,
Kubozono
T
,
Ikeda
Y
,
Fujita
S
,
Kuwahata
S
, et al
.
Waon therapy mobilizes CD34+ cells and improves peripheral arterial disease
.
J Cardiol
.
2010
;
56
(
3
):
361
6
.
36.
Perlow
S
.
Local diathermy in peripheral circulatory disturbances
.
J Am Med Assoc
.
1933
;
101
(
24
):
1869
71
.
37.
Guirro
ECDO
,
Guirro
RRDJ
,
Dibai-Filho
AV
,
Pascote
SCS
,
Rodrigues-Bigaton
D
.
Immediate effects of electrical stimulation, diathermy, and physical exercise on lower limb arterial blood flow in diabetic women with peripheral arterial disease: a randomized crossover trial
.
J Manip Physiol Ther
.
2015
;
38
(
3
):
195
202
.
38.
Landry
GJ
,
Louie
D
,
Giraud
D
,
Ammi
AY
,
Kaul
S
.
Ultrasound therapy for treatment of lower extremity intermittent claudication
.
American journal of surgery
.
Elsevier Inc.
;
2021
. p.
1271
5
.
39.
Neff
D
,
Kuhlenhoelter
AM
,
Lin
C
,
Wong
BJ
,
Motaganahalli
RL
,
Roseguini
BT
.
Thermotherapy reduces blood pressure and circulating endothelin-1 concentration and enhances leg blood flow in patients with symptomatic peripheral artery disease
.
Am J Physiol Regul Integr Comp Physiol
.
2016
;
311
(
2
):
R392
400
.
40.
Monroe
JC
,
Lin
C
,
Perkins
SM
,
Han
Y
,
Wong
BJ
,
Motaganahalli
RL
, et al
.
Leg heat therapy improves perceived physical function but does not enhance walking capacity or vascular function in pa-tients with peripheral artery disease
.
J Appl Physiol
.
2020
;
129
(
6
):
1279
89
.
41.
Monroe
JC
,
Song
Q
,
Emery
MS
,
Hirai
DM
,
Motaganahalli
RL
,
Roseguini
BT
.
Acute effects of leg heat therapy on walking performance and cardiovascular and inflammatory responses to exercise in patients with peripheral artery disease
.
Physiol Rep
.
2021
;
8
(
24
):
e14650
12
.
42.
Monroe
JC
,
Pae
BJ
,
Kargl
C
,
Gavin
TP
,
Parker
J
,
Perkins
SM
, et al
.
Effects of home-based leg heat therapy on walking performance in patients with symptomatic peripheral artery disease: a pilot randomized trial
.
J Appl Physiol
.
2022
;
133
(
3
):
546
60
.
43.
Ro
B
,
Spence
JP
,
Spence
PA
,
Buckley
C
,
Motaganahalli
RL
,
Roseguini
BT
.
Development and feasibility testing of a new device for home-based leg heat therapy in patients with lower extremity peripheral artery disease
.
J Vasc Surg Cases Innov Tech
.
2025
;
11
(
1
):
101676
.
44.
Thomas
KN
,
van Rij
AM
,
Lucas
SJE
,
Cotter
JD
.
Lower-limb hot-water immersion acutely induces beneficial hemodynamic and cardiovascular responses in peripheral arterial disease and healthy, elderly controls
.
Am J Physiol Regul Integr Comp Physiol
.
2017
;
312
(
3
):
R281
91
.
45.
Pellinger
TK
,
Neighbors
CB
,
Simmons
GH
.
Acute lower leg heating increases exercise capacity in patients with peripheral artery disease
.
J Cardiovasc Nurs
.
2019
;
34
(
2
):
130
3
.
46.
Savin
E
,
Bailliart
O
,
Bonnin
P
,
Bedu
M
,
Cheynel
J
,
Coudert
J
, et al
.
Vasomotor effects of transcutaneous CO2 in stage II peripheral occlusive arterial disease
.
Angiology
.
1995
;
46
(
9
):
785
91
.
47.
Hartmann
BR
,
Bassenge
E
,
Pittler
M
.
Effect of carbon dioxide-enriched water and fresh water on the cutaneous microcirculation and oxygen tension in the skin of the foot
.
Angiology
.
1997
;
48
(
4
):
337
43
.
48.
Makita
S
,
Ohira
A
,
Naganuma
Y
,
Abiko
A
,
Nakamura
M
.
The effects on skin blood flow of immersing the ischemic legs of patients with peripheral arterial disease into artificially carbonated water
.
Int J Angiol
.
2006
;
15
(
01
):
12
5
.
49.
Dogliotti
G
,
Galliera
E
,
Iorio
E
,
De Bernardi Di Valserra
M
,
Solimene
U
,
Corsi
MM
.
Effect of immersion in CO2-enriched water on free radical release and total antioxidant status in peripheral arterial occlu-sive disease
.
Int Angiol
.
2011
;
30
(
1
):
12
7
.
50.
Toriyama
T
,
Kumada
Y
,
Matsubara
T
,
Murata
A
,
Ogino
A
,
Hayashi
H
, et al
.
Effect of artificial carbon dioxide foot bathing on critical limb ischemia (Fontaine IV) in peripheral arterial disease patients
.
Int Angiol
.
2002
;
21
(
4
):
367
73
.
51.
Al-Jazzar
M
,
Aly
FA
,
Al-Omran
M
,
Alghadir
AH
,
Berika
MY
.
Therapeutic effect of an underwater exercise program for patients with peripheral arterial disease
.
J Phys Ther Sci
.
2012
;
24
(
8
):
687
90
.
52.
Quarto
G
,
Amato
B
,
Serra
R
,
Benassai
G
,
Monti
MG
,
Salzano
A
, et al
.
The effects of Crenotherapy and exercise in peripheral arterial occlusive disease. A comparison with simple exercise training
.
Ann Ital Chir
.
2017
;
88
(
6
):
469
77
.
53.
Yamane
H
,
Araki
R
,
Doi
A
,
Sato
F
,
Tanaka
K
,
Miyazaki
N
, et al
.
Successful wound healing of refractory digital ulcer in patient with systemic sclerosis by Waon therapy
.
J Cardiol Cases
.
2021
;
24
(
4
):
190
2
.
54.
Masuda
A
,
Koga
Y
,
Hattanmaru
M
,
Minagoe
S
,
Tei
C
.
The effects of repeated thermal therapy for patients with chronic pain
.
Psychother Psychosom
.
2005
;
74
(
5
):
288
94
.
55.
Harpuder
K
.
Physical medicine in peripheral vascular diseases
.
Med Clin North Am
.
1949
;
33
(
2
):
347
58
.
56.
Bennett
RL
,
Hines
EA
Jr
,
Krusen
FH
.
Effect of short-wave diathermy on the cutaneous temperatures of the feet
.
Am Heart J
.
1941
;
21
(
4
):
490
503
.
57.
Lu
ZY
,
Zhou
HS
,
Su
ZX
,
Qi
J
,
Zhang
J
,
Xue
GH
, et al
.
Therapeutic ultrasound plus pulsed electromagnetic field improves recovery from peripheral arterial disease in hypertension
.
Am J Transl Res
.
2017
;
9
(
9
):
4184
94
.
58.
Lu
ZY
,
Li
RL
,
Zhou
HS
,
Huang
JJ
,
Su
ZX
,
Qi
J
, et al
.
Therapeutic ultrasound reverses peripheral ischemia in type 2 diabetic mice through PI3K-Akt-eNOS pathway
.
Am J Transl Res
.
2016
;
8
(
9
):
3666
77
.
59.
Nazer
B
,
Ghahghaie
F
,
Kashima
R
,
Khokhlova
T
,
Perez
C
,
Crum
L
, et al
.
Therapeutic ultrasound promotes reperfusion and angiogenesis in a rat model of peripheral arterial disease
.
Circ J
.
2015
;
79
(
9
):
2043
9
.
60.
Said
M
,
Ghoneim
B
,
Jones
J
,
Tawfick
W
.
The effects of sedentary behaviour on patients with peripheral arterial Disease: a systematic review
.
Prev Med Rep
.
2023
;
36
(
April
):
102424
.
61.
Brunt
VE
,
Howard
MJ
,
Francisco
MA
,
Ely
BR
,
Minson
CT
.
Passive heat therapy improves endothelial function, arterial stiffness and blood pressure in sedentary humans
.
J Physiol
.
2016
;
594
(
18
):
5329
42
.
62.
Brunt
VE
,
Eymann
TM
,
Francisco
MA
,
Howard
MJ
,
Minson
CT
.
Passive heat therapy improves cutaneous microvascular function in sedentary humans via improved nitric oxide-dependent dilation
.
J Appl Physiol
.
2016
;
121
(
3
):
716
23
.
63.
Leppäluoto
J
,
Tuominen
M
,
Väänänen
A
,
Karpakka
J
,
Vuori
J
.
Some cardiovascular and metabolic effects of repeated sauna bathing
.
Acta Physiol Scand
.
1986
;
128
(
1
):
77
81
.
64.
Su
Y
,
Hoekstra
SP
,
Leicht
CA
.
Hot water immersion is associated with higher thermal comfort than dry passive heating for a similar rise in rectal temperature and plasma interleukin-6 concentration
.
Eur J Appl Physiol
.
2024
;
124
(
4
):
1109
19
.
65.
Elimban
V
,
Xu
YJ
,
Bhullar
SK
,
Dhalla
NS
.
Temperature-dependent effects on CO2 water bath therapy induced changes in blood flow and vascularity in hind limb ischemia
.
Can J Physiol Pharmacol
.
2020
;
98
(
4
):
228
35
.
66.
Hunter
SD
,
Dhindsa
MS
,
Cunningham
E
,
Tarumi
T
,
Alkatan
M
,
Nualnim
N
, et al
.
The effect of Bikram yoga on endothelial function in young and middle-aged and older adults
.
J Bodyw Mov Ther
.
2017
;
21
(
1
):
30
4
.
67.
Hewett
ZL
,
Cheema
BS
,
Pumpa
KL
,
Smith
CA
.
The effects of bikram yoga on health: critical review and clinical trial recommendations
.
Evid Based Complement Alternat Med
.
2015
;
2015
(
2
):
428427
.
68.
Bourbeau
KC
,
Moriarty
TA
,
Bellovary
BN
,
Bellissimo
GF
,
Ducharme
JB
,
Haeny
TJ
, et al
.
Cardiovascular, cellular, and neural adaptations to hot yoga versus normal-temperature yoga
.
Int J Yoga
.
2021
;
14
(
2
):
115
26
.
69.
Guo
YH
,
Wang
F
,
Hu
JP
,
Wang
Y
,
Zhang
LY
.
Effect of high temperature yoga exercise on improving physical and mental well-being of overweight middle-aged and young women
.
Int J Clin Exp Med
.
2014
;
7
(
12
):
5842
6
.
70.
Hunter
SD
,
Dhindsa
MS
,
Cunningham
E
,
Tarumi
T
,
Alkatan
M
,
Nualnim
N
, et al
.
The effect of bikram yoga on arterial stiffness in young and older adults
.
J Altern Complement Med
.
2013
;
19
(
12
):
930
4
.
71.
Velde
SVD
,
Byrd
B
,
Dalleck
L
.
Effects of exercise training with a sauna suit on cardiovascular health: a proof-of-concept study
.
Int J Res Ex Phys
.
2016
;
11
(
1
):
1
10
.
72.
Rissanen
JA
,
Häkkinen
K
,
Laukkanen
JA
,
Häkkinen
A
.
Acute hemodynamic responses to combined exercise and sauna
.
Int J Sports Med
.
2020
;
41
(
12
):
824
31
.
73.
Lee
E
,
Kolunsarka
I
,
Kostensalo
J
,
Ahtiainen
JP
,
Haapala
EA
,
Willeit
P
, et al
.
Effects of regular sauna bathing in conjunction with exercise on cardiovascular function: a multi-arm, randomized con-trolled trial
.
Am J Physiol Regul Integr Comp Physiol
.
2022
;
323
(
3
):
R289
99
.
74.
Caldwell
AR
,
Robinson
FB
,
Tucker
MA
,
Arcement
CH
,
Butts
CL
,
McDermott
BP
, et al
.
Effect of passive heat stress and exercise in the heat on arterial stiffness
.
Eur J Appl Physiol
.
2017
;
117
(
8
):
1679
87
.
75.
Notley
SR
,
Poirier
MP
,
Sigal
RJ
,
D’Souza
A
,
Flouris
AD
,
Fujii
N
, et al
.
Exercise heat stress in patients with and without type 2 diabetes
.
JAMA J Am Med Assoc
.
2019
;
322
(
14
):
1409
11
.
76.
Macartney
MJ
,
Notley
SR
,
Herry
CL
,
Sigal
RJ
,
Boulay
P
,
Kenny
GP
.
Effect of exercise-heat acclimation on cardiac autonomic modulation in type 2 diabetes: a pilot study
.
Appl Physiol Nutr Metabol
.
2021
;
46
(
3
):
284
7
.
77.
Akasaki
Y
,
Miyata
M
,
Eto
H
,
Shirasawa
T
,
Hamada
N
,
Ikeda
Y
, et al
.
Repeated thermal therapy up-regulates endothelial nitric oxide synthase and augments angiogenesis in a mouse model of hindlimb ischemia
.
Circ J
.
2006
;
70
(
4
):
463
70
.
78.
Wilkinson
IB
,
MacCallum
H
,
Cockcroft
JR
,
Webb
DJ
.
Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo
.
Br J Clin Pharmacol
.
2002
;
53
(
2
):
189
92
.
79.
Baek
SH
,
Min
JN
,
Park
EM
,
Han
MY
,
Lee
YS
,
Lee
YJ
, et al
.
Role of small heat shock protein HSP25 in radioresistance and glutathione-redox cycle
.
J Cell Physiol
.
2000
;
183
(
1
):
100
7
.
80.
Pritchard
KA
,
Ackerman
AW
,
Gross
ER
,
Stepp
DW
,
Shi
Y
,
Fontana
JT
, et al
.
Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase
.
J Biol Chem
.
2001
;
276
(
21
):
17621
4
.
81.
Kim
IK
,
Shin
HM
,
Baek
W
.
Heat-shock response is associated with decreased production of interleukin-6 in murine aortic vascular smooth muscle cells
.
Naunyn Schmiedebergs Arch Pharmacol
.
2005
;
371
(
1
):
27
33
.
82.
Welc
SS
,
Phillips
NA
,
Oca-Cossio
J
,
Wallet
SM
,
Chen
DL
,
Clanton
TL
.
Hyperthermia increases interleukin-6 in mouse skeletal muscle
.
Am J Physiol Cell Physiol
.
2012
;
303
(
4
):
C455
66
.
83.
Lee
CT
,
Kokolus
KM
,
Leigh
ND
,
Capitano
M
,
Hylander
BL
,
Repasky
EA
.
Defining immunological impact and therapeutic benefit of mild heating in a murine model of arthritis
.
PLoS One
.
2015
;
10
(
3
):
e0120327
19
.
84.
Normand-Gravier
T
,
Solsona
R
,
Dablainville
V
,
Racinais
S
,
Borrani
F
,
Bernardi
H
, et al
.
Effects of thermal interventions on skeletal muscle adaptations and regeneration: perspectives on epigenetics: a narrative review
.
Eur J Appl Physiol
.
2025
;
125
(
2
):
277
301
.
85.
Tamura
Y
,
Kitaoka
Y
,
Matsunaga
Y
,
Hoshino
D
,
Hatta
H
.
Daily heat stress treatment rescues denervation-activated mitochondrial clearance and atrophy in skeletal muscle
.
J Physiol
.
2015
;
593
(
12
):
2707
20
.
86.
Hafen
PS
,
Abbott
K
,
Bowden
J
,
Lopiano
R
,
Hancock
CR
,
Hyldahl
RD
.
Daily heat treatment maintains mitochondrial function and attenuates atrophy in human skeletal muscle subjected to immobilization
.
J Appl Physiol
.
2019
;
127
(
1
):
47
57
.
87.
Criqui
MH
,
Aboyans
V
.
Epidemiology of peripheral artery disease
.
Circ Res
.
2015
;
116
(
9
):
1509
26
.
88.
Guergova
S
,
Dufour
A
.
Thermal sensitivity in the elderly: a review
.
Ageing Res Rev
.
2011
;
10
(
1
):
80
92
.
89.
Minson
CT
,
Holowatz
LA
,
Wong
BJ
,
Kenney
WL
,
Wilkins
BW
.
Copyright 2002 by the. American Physiological Society
.
2002
;
541
.
90.
Bruning
RS
,
Santhanam
L
,
Stanhewicz
AE
,
Smith
CJ
,
Berkowitz
DE
,
Kenney
WL
, et al
.
Endothelial nitric oxide synthase mediates cutaneous vasodilation during local heating and is attenuated in middle-aged human skin
.
J Appl Physiol
.
2012
;
112
(
12
):
2019
26
.
91.
Sheen
YJ
,
Li
TC
,
Lin
JL
,
Tsai
WC
,
Kao
CD
,
Bau
CT
, et al
.
Association between thermal threshold abnormalities and peripheral artery disease in patients with type 2 diabetes
.
Med
.
2018
;
97
(
51
):
e13803
.
92.
Stephens
JM
,
Argus
C
,
Driller
MW
.
The relationship between body composition and thermal responses to hot and cold water immersion
.
J Hum Perform Extreme Environments
.
2014
;
11
(
2
).
93.
Martin
NA
,
Falder
S
.
A review of the evidence for threshold of burn injury
.
Burns
.
2017
;
43
(
8
):
1624
39
.
94.
Petrofsky
JS
,
Laymon
M
.
Heat transfer to deep tissue: the effect of body fat and heating modality
.
J Med Eng Technol
.
2009
;
33
(
5
):
337
48
.
95.
Popkin
RJ
.
Dangers of local external heat and trauma to ischemic tissues in peripheral vascular diseases
.
Calif Med
.
1948
;
69
(
5
):
374
.
96.
MacIntyre
BA
,
Bullard
RW
,
Banerjee
M
,
Elizondo
R
.
Mechanism of enhancement of eccrine sweating by localized heating
.
J Appl Physiol
.
1968
;
25
(
3
):
255
60
.
97.
Lowe
GDO
,
Fowkes
FGR
,
Dawes
J
,
Donnan
PT
,
Lennie
SE
,
Housley
E
, et al
.
Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh artery study
.
Circulation
.
1993
;
87
(
6
):
1915
20
.